About Technology Issues FAQ

Links

Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer (RAVELLO trial).

Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer (RAVELLO trial). — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.